tacrine has been researched along with liquiritigenin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cho, IJ; Han, NR; Ki, SH; Kim, SC; Kim, YW; Ku, SK; Park, SM; Zhao, RJ | 1 |
1 other study(ies) available for tacrine and liquiritigenin
Article | Year |
---|---|
Tacrine, an oral acetylcholinesterase inhibitor, induced hepatic oxidative damage, which was blocked by liquiritigenin through GSK3-beta inhibition.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Cell Line; Cell Survival; Chemical and Drug Induced Liver Injury; Cholinesterase Inhibitors; Flavanones; Glutathione; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hep G2 Cells; Humans; Hydrogen Peroxide; Liver; Mice; Oxidative Stress; Protective Agents; Rats; Rats, Sprague-Dawley; Tacrine | 2015 |